Stockscreener 앱 받기
9.49
2.50%
0.25
전일 마감가:
$9.24
열려 있는:
$9.4
하루 거래량:
186.13K
Relative Volume:
0.26
시가총액:
$879.79M
수익:
$81.39M
순이익/손실:
$-114.20M
주가수익비율:
-6.6582
EPS:
-1.4253
순현금흐름:
$-50.60M
1주 성능:
+3.74%
1개월 성능:
+2.61%
6개월 성능:
+15.50%
1년 성능:
+85.71%
1일 변동 폭
$9.285
$9.67
1주일 범위
$9.195
$9.80
52주 변동 폭
$5.0201
$11.85
Meiragtx Holdings Plc Stock (MGTX) Company Profile
명칭
Meiragtx Holdings Plc
전화
646-860-7985
주소
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
9.50 | 855.71M | 81.39M | -114.20M | -50.60M | -1.4253 |
VRTX
Vertex Pharmaceuticals Inc
|
437.70 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
639.70 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
809.31 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.04 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.64 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 개시 | H.C. Wainwright | Buy |
| 2025-10-21 | 개시 | Raymond James | Strong Buy |
| 2024-07-31 | 재개 | Chardan Capital Markets | Buy |
| 2020-10-23 | 개시 | RBC Capital Mkts | Outperform |
| 2020-09-15 | 재개 | BofA Securities | Buy |
| 2019-09-03 | 개시 | Piper Jaffray | Overweight |
| 2019-02-27 | 재확인 | Chardan Capital Markets | Buy |
| 2018-07-03 | 개시 | Barclays | Overweight |
| 2018-07-03 | 개시 | BofA/Merrill | Buy |
모두보기
Meiragtx Holdings Plc 주식(MGTX)의 최신 뉴스
MeiraGTx Holdings | 4: Statement of changes in beneficial ownership of securities-Officer Wollin Robert J - Moomoo
Chardan Capital Maintains MeiraGTx Holdings (MGTX) Buy Recommendation - MSN
MeiraGTx Holdings PLC (MGTX) reports Q1 loss, lags revenue estimates - MSN
MeiraGTx Holdings stock (US58550P1012): Insider selling draws attention as gene therapy story evolve - AD HOC NEWS
Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint - Insider Monkey
Meiragtx president & CEO Forbes Alexandria sells $568,540 in shares - Investing.com India
Insider Sell Alert: Alexandria Forbes Sells 62,000 Shares of Mei - GuruFocus
Meiragtx president & CEO Forbes Alexandria sells $568,540 in shares By Investing.com - Investing.com South Africa
MeiraGTx (MGTX) CEO sells 62,000 shares under Rule 10b5-1 plan - Stock Titan
MGTX (NASDAQ) affiliate lists 62,000-share sale in Form 144 filing - Stock Titan
10 Best Gene Therapy Stocks to Buy in 2026 - Insider Monkey
MeiraGTx Holdings stock (US58550P1012): gene therapy player in focus after recent earnings and partn - AD HOC NEWS
MeiraGTx Holdings plc (NASDAQ:MGTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - Sahm
Understanding Momentum Shifts in (MGTX) - Stock Traders Daily
Here's What Analysts Are Forecasting For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its First-Quarter Results - Yahoo Finance
MeiraGTx Falls 5.5% as MGTX Shares Slip, Investors Keep Watch Next Week - TechStock²
Will MeiraGTx Holdings PLC (MGTX) report negative Q1 earnings? What you should know - MSN
MGTX Maintained by RBC Capital -- Price Target Raised to $25.00 - GuruFocus
MeiraGTx (NASDAQ:MGTX) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - MarketBeat
RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $25 - Moomoo
RBC Raises Price Target on MeiraGTx Holdings to $25 From $24, Keeps Outperform, Speculative Risk - marketscreener.com
Strength seen in MeiraGTx (MGTX): Can its 6.2% jump turn into more strength? - MSN
MeiraGTx Reports First Quarter 2026 Financial and Operational Results - Investing News Network
MeiraGTx (MGTX) Chief Development Officer listed as insider in new Form 3 - Stock Titan
MeiraGTx (MGTX) CDO awarded 100,000 RSUs and 100,000 stock options - Stock Titan
MeiraGTx (MGTX) Reports Q1 Revenue Figures and Significant Progr - GuruFocus
MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
MeiraGTx Holdings PLC (MGTX) Q4 earnings and revenues surpass estimates - MSN
MeiraGTx Holdings plc Q1 2026 10-Q Report: Financial Results, Risk Factors, and Business Overview - Minichart
MeiraGTx Reports Q1 2026 Results: FDA Breakthrough Therapy, Bota-vec Acquisition, Positive Clinical Data, and $100M Financing - Minichart
MeiraGTx Holdings PLC reports results for the quarter ended March 31Earnings Summary - TradingView
MeiraGTx Holdings Releases Q1 2026 Financial Results - AlphaStreet
MeiraGTx Holdings plc Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Is MeiraGTx (MGTX) a Possible Value Trap After Q1 2026? EPS -$0. - GuruFocus
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
MeiraGTx's Q1 Adjusted Loss Widens, Revenue Declines; Share Up Pre-Bell - marketscreener.com
Earnings Flash (MGTX) MeiraGTx Posts Q1 Adjusted Net Loss $0.57 a Share, vs. FactSet Est of $0.75 Loss - marketscreener.com
Earnings Flash (MGTX) MeiraGTx Holdings plc Reports Q1 Revenue $0.3M, vs. FactSet Est of $17.0M - marketscreener.com
MeiraGTx Holdings plc 1Q 2026: Revenue $293K, EPS ($0.57) — 10-Q Summary - TradingView
MeiraGTx (MGTX) deepens Janssen, Lilly and Hologen ties while posting Q1 2026 loss - Stock Titan
MeiraGTx reports Q1 2026 results: $0.3M revenue, $46.3M net loss, $73.8M cash - TradingView
MeiraGTx Holdings 1Q Loss/Shr 57c >MGTX - Moomoo
Regulatory wins and $100M raise reshape MeiraGTx (MGTX) pipeline outlook - Stock Titan
Earnings Flash (MGTX) MeiraGTx Holdings Plc Reports Q1 Revenue $0.3M, Vs. FactSet Est of $17.0M - Moomoo
Press Release: MeiraGTx Reports First Quarter 2026 Financial and Operational Results - Moomoo
MeiraGTx Holdings (NASDAQ:MGTX) Passes Minervini Trend Template and High Growth Momentum Screen - ChartMill
Adage Capital (MGTX) reports 4,000,000-share holding, 4.91% stake - Stock Titan
MeiraGTx Holdings stock (US58550P1012): Q1 earnings report due May 12 - AD HOC NEWS
Number of shareholders of MeiraGTx Holdings Plc – LS:A2JGHF - TradingView
MSN Money - MSN
MeiraGTx Holdings plc (MGTX) Stock Analysis: Unpacking a Promising 188% Upside in Biotech Innovation - DirectorsTalk Interviews
Meiragtx Holdings Plc (MGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.25%
0.46%
자본화:
|
볼륨(24시간):